uPAR/MMP-9 silencing switches the glycolytic metabolism of glioma cells to oxidative phosphorylation (OXPHOS) and generates reactive oxygen species (ROS) to predispose glioma cells to mitochondrial outer membrane permeabilization. This evidence concerns the gene PLAUR and central nervous system cancer.